Thomas Olin

Currently holds a position at Kancera AB

3.0

3.0

Position	Company	Period
Member of the Management, Chief Executive Officer, Director	Kancera AB	None -
Independent Director	Klaria Pharma Holding AB (publ)	None -
Chief Executive Officer, Director	SaltX Technology Holding AB	Dec. 18, 2015 - April 7, 2016

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2024-03-08	2024-03-06	Kancera AB (KAN)	B Purchase	57,155 412.08 SEK3,757,369	57,155	412.08	SEK3,757,369
2022-11-14	2022-11-04	Kancera AB (KAN)	B Purchase	70,133 389.76 SEK4,120,729	70,133	389.76	SEK4,120,729
2022-11-04	2022-11-04	Kancera AB (KAN)	B Purchase	19,460 41.46 SEK3,486,092	19,460	41.46	SEK3,486,092
2021-05-14	2021-05-12	Kancera AB (KAN)	B Purchase	13,001 12.70 SEK165,113	13,001	12.70	SEK165,113
2020-10-01	2020-09-30	Kancera AB (KAN)	B Purchase	98,263 0.47 SEK46,184	98,263	0.47	SEK46,184
2020-03-26	2020-03-25	Kancera AB (KAN)	B Purchase	196,527 0.39 SEK76,646	196,527	0.39	SEK76,646
2018-05-17	2018-05-16	Kancera AB (KAN)	B Purchase	125,000 1.20 SEK150,000	125,000	1.20	SEK150,000
2017-06-01	2017-05-30	Kancera AB (KAN)	B Purchase	14,230 1.80 SEK25,614	14,230	1.80	SEK25,614
2017-06-01	2017-05-30	Kancera AB (KAN)	B Purchase	55,795 1.80 SEK100,431	55,795	1.80	SEK100,431
2017-05-19	2017-05-18	Kancera AB (KAN)	S Sale	300,000 0.08 SEK23,625	300,000	0.08	SEK23,625
2017-05-19	2017-05-17	Kancera AB (KAN)	S Sale	300,000 0.07 SEK22,125	300,000	0.07	SEK22,125